Evaluation of Viscosity of a Vaginal Moisturizer

Farmoquimica

Status and phase

Unknown

Phase 4

Conditions

Menopausal Women

Vaginal Dryness

Treatments

Device: sodium lactate and combination of polymers

Study type

Interventional

Funder types

Industry

Identifiers

NCT03782961

FE4 - HIDRAFEMME - PA - 010

Details and patient eligibility

About

To evaluate the perception of viscosity of a vaginal moisturizer in postmenopausal women

Full description

A unicentric, blind, non-comparative clinical study to prove the perceived efficacy of the research product.

It will be necessary 33 female research participants, aged between 45 and 70 years menopause with complaint of vaginal dryness.

The participant will remain in the study for one day, making use of the research product in the Research Center.

Participants will be divided into 2 groups so that each group observes the viscosity (flow) of the test product in a different anatomical position (lying down and standing) immediately after application of the product, after 15 and 30 minutes.

Participants will respond to a subjective assessment using a standardized questionnaire to capture possible feelings of discomfort during the study.

A gynecologist will be available to monitor the participants throughout the study.

Enrollment

33 estimated patients

Sex

Female

Ages

45 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Menopausal participants for at least 6 months;
Participants with complaints of vaginal dryness;
Skin integrity in the region of product analysis;
Agreement to comply the procedures of the trial and attend the clinic on the days and times determined for applications and / or evaluations;
Understanding, agreement and signing of the Informed Consent Term.

Exclusion criteria

Use of anti-inflammatory / immunosuppressive / antihistamine drugs up to 3 weeks prior to selection;
Pathologies and / or active skin lesions (local and / or disseminated) in the evaluation area;
Immunosuppression by drugs or active diseases;
Decompensated endocrinopathies;
Relevant clinical history or current evidence of alcohol or other drug abuse;
known history or suspected intolerance to products of the same category;
Intense sun exposure up to 15 days before evaluation;
Gynecological treatment up to 4 weeks before evaluation;
Other conditions considered by the researcher to be reasonable for disqualification of study participation.